share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Apr 20 07:05
Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 17, 2024. The transactions were executed in the open market with prices ranging from $103.0983 to $104.4896 per share, resulting in a total market value of approximately $1,550,703. After the sale, Afeyan directly holds 2,056,931 shares of Moderna. Additionally, Afeyan has an indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 17, 2024. The transactions were executed in the open market with prices ranging from $103.0983 to $104.4896 per share, resulting in a total market value of approximately $1,550,703. After the sale, Afeyan directly holds 2,056,931 shares of Moderna. Additionally, Afeyan has an indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.